Skip to main content

opioids

By Alexandra Mullin and Ian Chiang | 02:16 pm | January 29, 2021
Flare Capital's Alexandra Mullin and Ian Chiang outline COVID-19's impact on the worsening opioid crisis and how the digital opioid use disorder space is likely to develop over the coming years.
By Dave Muoio | 02:55 pm | November 05, 2020
The study, backed by the digital therapeutics company, measured the change in clinical encounter frequency among opioid use disorder patients who were also prescribed buprenorphine.
By Dave Muoio | 05:21 pm | January 28, 2020
The Silicon Valley EHR vendor received “sponsorship” payments from unnamed pharmaceutical companies so that the latter’s marketing team could influence the design of CDS features, according to the Department of Justice.
By Laura Lovett | 03:36 pm | January 31, 2019
Customers will have a text chat-based consultation with a doctor through the platform, who will instruct them about when and how to use the medication. 
By Jonah Comstock | 05:00 pm | December 03, 2018
The eight devices will receive increased guidance and interaction for their clearance efforts, and some will receive Breakthrough Device designation.
By Laura Lovett | 01:16 pm | October 25, 2018
Trump invited 21 companies to the White House signing of the bill, including Amazon, which unveiled a new AWS Opioid Crisis Council.